Status:
ACTIVE_NOT_RECRUITING
Sugars in Cigarettes
Lead Sponsor:
Masonic Cancer Center, University of Minnesota
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Tobacco Use
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The aim of this study is to investigate the impact of sugar levels in cigarette tobacco on cigarette abuse liability and appeal. Participants will attend several clinic visits to smoke cigarettes with...
Eligibility Criteria
Inclusion
- Male or female age 21 years or older
- Smoking cigarettes that have been evaluated to have medium levels of sugar content
- No quit attempts in the past month nor intentions to quit smoking in the next month
- Participants are in good physical health (no unstable medical conditions) as determined by the licensed medical professional
- Participants are in stable, good mental health (e.g. not currently, within the past 6 months, experiencing unstable or untreated psychiatric diagnosis) as determined by the licensed medical professional
- Stable vitals sign measurements (systolic BP ≤ 160 and \>90 mmHg, diastolic BP ≤ 100 and \>50 mmHg and heart rate ≤105 and \> 45 bpm) as determined by the licensed medical professional
- Participants must be able to read for comprehension or completion of study documents (confirmed during informed consent process)
- Participants have provided written informed consent to participate in the study.
Exclusion
- Significant immune system disorders, respiratory diseases, kidney or liver diseases or any other medical disorders that may affect biomarker data as determined by the licensed medical professional
- Women who are pregnant or nursing or planning to become pregnant.
Key Trial Info
Start Date :
February 24 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05308316
Start Date
February 24 2022
End Date
May 1 2026
Last Update
January 6 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Masonic Cancer Center at University of Minnesota
Minneapolis, Minnesota, United States, 55455